Andrea S. Kreienbuhl

Zurich, ZH, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Pathways of Epithelial Barrier Breakdown and Remodeling in Esophageal Organoids by Commonly Used Surfactants.

Pathways of Epithelial Barrier Breakdown and Remodeling in Esophageal Organoids by Commonly Used Surfactants.

Journal: Allergy

Published: April 02, 2026

Bilateral Lower Lip Swelling as an Early Manifestation of Crohn's Disease in a 16-Year-Old Patient: A Case Report.

Bilateral Lower Lip Swelling as an Early Manifestation of Crohn's Disease in a 16-Year-Old Patient: A Case Report.

Journal: Case reports in dentistry

Published: March 19, 2026

Role of A2 beta casein in milk-induced eosinophilic oesophagitis: novel in-vivo and in-vitro findings.

Role of A2 beta casein in milk-induced eosinophilic oesophagitis: novel in-vivo and in-vitro findings.

Journal: Gut

Published: November 19, 2025

Clinical Utility of Intestinal Ultrasound for Guiding Therapy in Inflammatory Bowel Disease: A Retrospective Real-World Cohort from a Swiss Tertiary Center.

Clinical Utility of Intestinal Ultrasound for Guiding Therapy in Inflammatory Bowel Disease: A Retrospective Real-World Cohort from a Swiss Tertiary Center.

Journal: Digestive diseases (Basel, Switzerland)

Published: July 22, 2025

Open-label, Phase 2a Pilot Study Evaluating the Efficacy and Tolerability of Topical Mesalamine Treatment in Adult Patients With Active Eosinophilic Esophagitis.

Open-label, Phase 2a Pilot Study Evaluating the Efficacy and Tolerability of Topical Mesalamine Treatment in Adult Patients With Active Eosinophilic Esophagitis.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: July 14, 2025

Correction: Clinical effectiveness of esophageal stricture dilation using an improved endoscopic attachment cap in adults with eosinophilic esophagitis.

Correction: Clinical effectiveness of esophageal stricture dilation using an improved endoscopic attachment cap in adults with eosinophilic esophagitis.

Journal: Endoscopy

Published: June 18, 2025

Clinical effectiveness of esophageal stricture dilation using an improved endoscopic attachment cap in adults with eosinophilic esophagitis.

Clinical effectiveness of esophageal stricture dilation using an improved endoscopic attachment cap in adults with eosinophilic esophagitis.

Journal: Endoscopy

Published: June 04, 2025

Wide discrepancy between best practice recommendations and real-life management of suspected eosinophilic esophagitis-associated food bolus impaction.

Wide discrepancy between best practice recommendations and real-life management of suspected eosinophilic esophagitis-associated food bolus impaction.

Journal: Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus

Published: May 09, 2025

Eosinophilic esophagitis patients report substantial disease burden comparable to more systemic immune-mediated diseases.

Eosinophilic esophagitis patients report substantial disease burden comparable to more systemic immune-mediated diseases.

Journal: BMC gastroenterology

Published: March 04, 2025

Long-Term Outcome of Ciclosporin and Infliximab as Rescue Therapy in Steroid-Refractory Acute Severe Ulcerative Colitis.

Long-Term Outcome of Ciclosporin and Infliximab as Rescue Therapy in Steroid-Refractory Acute Severe Ulcerative Colitis.

Journal: Inflammatory intestinal diseases

Published: January 02, 2025

Circulating Food Allergen-Specific Antibodies, Beyond IgG4, Are Elevated in Eosinophilic Esophagitis.

Circulating Food Allergen-Specific Antibodies, Beyond IgG4, Are Elevated in Eosinophilic Esophagitis.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Published: November 25, 2024

Loss of Response to Off-Label Swallowed Topical Corticosteroids in Eosinophilic Esophagitis Can be Overcome by a Switch to an Esophageal-Targeted Budesonide Formulation.

Loss of Response to Off-Label Swallowed Topical Corticosteroids in Eosinophilic Esophagitis Can be Overcome by a Switch to an Esophageal-Targeted Budesonide Formulation.

Journal: The American journal of gastroenterology

Published: November 14, 2024

Showing 1-12 of 22

Last Updated: 09/26/2026